Skip to main content

Table 2 Definitions of major complications of pancreatic extracorporeal shock wave lithotripsy

From: Rectally administered indomethacin to prevent post-ESWL-pancreatitis (RIPEP): study protocol for a randomized controlled trial

Complications

Mild

Moderate

Severe

Post-ESWL pancreatitis

Clinical pancreatitis, amylase at least three times the normal level at > 24 h after procedure, requires admission or extension of planned admission from 2 days to 3 days

Requires hospitalization of 4– 10 days

Hospitalization for > 10 days, pseudocyst formation, or intervention (percutaneous drainage or surgery)

Bleeding

Clinical evidence of bleeding, hemoglobin fall < 3 g, no transfusion

Transfusion of ≤ 4 units, no angiographic intervention, or surgery

Transfusion of ≥ 5 units, or intervention (angiographic or surgical)

Infection

>38 °C for 24–48 h

Requires > 3 days of hospital treatment

Abscess, septic shock, or intervention (percutaneous drainage or surgery)

Steinstrasse

Severe abdominal pain without other post-ESWL complications

Combined with other complications, or requires > 3 days of hospital treatment

Combined with other complications; hospitalization for > 10 days, or surgery

Perforation

Possible, or very slight leak of fluid, treatable with fluids and suction for ≤ 3 days

Any definite perforation treated medically for 4–10 days

Medical treatment for > 10 days, or intervention (percutaneous or surgical)

  1. ESWL extracorporeal shock wave lithotripsy